- Country: USA
- Summary: NOI to Sole Source 17 Nucleocounter® NC-202 devices with IOPQ kits
- UST Ref No: 118542805
- Deadline: 15 May 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: 25-005553
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Description
17 Nucleocounter® NC-202 devices with IOPQ kits
Product Service Code: 6640 NAICS Code: 334516 Place of Performance:Bethesda, MD 20892 USA
POTS: 25-005553
Description
This is a notice of intent, NOT a request for a quotation. A solicitation document will NOT be issued, and quotations will NOT be requested.
The National Institutes of Health (NIH) intends to award a firm fixed-price purchase order on a sole-source basis to Chemometec Inc. of 3920 Veterans Memorial Highway, Suite 3, Bohemia, New York 11716-1074. This award will be for the procurement of 17 Nucleocounter® NC-202™ Devices with IOPQ kits for the Center for Cellular Engineering.
The purpose of this acquisition is to procure seventeen (17) Nucleocounter® NC-202™ Devices with IQ/OQ/PQ kits. These devices will be used to quantify cell numbers in cell therapy products intended for patients. The FDA requires accurate quantification of cell numbers to determine the correct dosage for cell therapies. Inaccurate cell quantification can expose patients to potential risks, including:
Inadequate dosages that may not effectively treat the patient. Overdosages, which may lead to side effects like cytokine storm.The Nucleocounter® NC-202™ is a widely used device in cell therapy and comes with a suitable IQ/OQ/PQ package to meet FDA expectations. The device is capable of counting cell concentrations up to 1x10^7 cells per ml, even in samples with significant red blood cell contamination.
The device supports the following applications:
Count & Viability - For most mammalian cell types (e.g., cancer cells, HEK cells). PBMC - For immune cells (e.g., PBMCs, T-cells, B-cells). Large Single Cells - For hepatocytes, MSCs. Aggregated Cells - For stem cells, tissue-derived cell lines. Microcarriers - For cell culture on microcarriers. Blood - For whole blood or samples with high RBC counts. CEF - For chicken embryo fibroblasts. Insect Cells - For ... - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINNOI to Sole Source 17 Nucleocounter® NC-202 devices with IOPQ kits - USA Tender
The HEALTH AND HUMAN SERVICES, DEPARTMENT OF | NATIONAL INSTITUTES OF HEALTH, a Government sector organization in USA, has announced a new tender for NOI to Sole Source 17 Nucleocounter® NC-202 devices with IOPQ kits. This tender is published on USARFP under UST Ref No: 118542805 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-05-15.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
